H.C. Wainwright analyst Joseph Pantginis raised the firm’s price target on IMV Inc. to $65 from $13 to reflect the recent 1-for-10 reverse split. HE keeps a Buy rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IMV:
- Biotech Alert: Searches spiking for these stocks today
- IMV Inc. announces $9M registered direct offering priced ATM
- IMV Blasts Up after New Test Data Emerges
- IMV Inc. to present initial patient data from VITALIZE trial
- IMV begins trading on the TSX and Nasdaq post-reverse stock split
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue